46 Member Networks and Programs Receive Commendations in 2023 for Research Performance

Trial Spotlight: A Closer Look at ECOG-ACRIN’s Lung Cancer Studies
December 19, 2023
Female doctor in scrubs on iPad
Opportunity Knocks: Harnessing the Skills of Advanced Practice Providers for Cancer Clinical Research
December 19, 2023
Trial Spotlight: A Closer Look at ECOG-ACRIN’s Lung Cancer Studies
December 19, 2023
Female doctor in scrubs on iPad
Opportunity Knocks: Harnessing the Skills of Advanced Practice Providers for Cancer Clinical Research
December 19, 2023

46 Member Networks and Programs Receive Commendations in 2023 for Research Performance

Evaluation Form

Each year, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) conducts an Institution Evaluation in which a subset of Principal Investigator (PI) Committee members and senior administrators meet to evaluate the performance of ECOG-ACRIN member networks and programs. The exceptional staff in the Membership Department facilitates the process—encompassing nearly 1500 individual research institutions in total, comprising 140 research programs. Through this annual review, principal investigators and research personnel stay informed about the many scientific and administrative components that comprise ECOG-ACRIN's expectations for retaining membership in the Group. In addition, the evaluation ensures that member institutions maintain ECOG-ACRIN's high standards to conduct cancer research with and through the Group.

Data from the previous calendar year (2022) was evaluated. The following areas are part of the review: accrual, clinical data quality and timeliness, compliance with requirements for submission of laboratory samples and images, scientific leadership, administrative contribution, and compliance with policies of both ECOG-ACRIN and the National Cancer Institute (NCI) through its National Clinical Trials Network audit process. The review committee is blinded to the identity of the institutions during this initial evaluation when they give a numerical rating to these categories. However, final unblinded assessments are based on both the objective data and discussions on the unique aspects of each institution that cannot be captured in a numerical rating.

For 2023, the review committee voted to commend the following 46 networks and NCI Community Oncology Research Programs (NCORPs). Group Co-Chairs Peter O'Dwyer, MD, and Mitchell Schnall, MD, PhD, recognized them during the General Session of the Fall 2023 Group Meeting.

Overall Outstanding Performance

Institution

Principal Investigator

Aultman Health Foundation/Timken Family Cancer Center

Sunitha Vemulapalli, MD

Delaware/Christiana Care NCORP

Gregory A. Masters, MD

Heartland Cancer Research NCORP

Bryan A. Faller, MD

Memorial Sloan Kettering Cancer Center

Christopher E. Comstock, MD

Metro-Minnesota Community Oncology Research Consortium NCORP

David M. King, MD

National Cancer Center Korea

Ji-Youn Han, MD

New York University/NYU Langone Perlmutter Cancer Center

Catherine S. Diefenbach, MD

Pacific Cancer Research Consortium NCORP

Charles W. Drescher, MD

Southeast Clinical Oncology Research Consortium NCORP

Judith O. Hopkins, MD

Stanford University/Standard Cancer Institute

Melinda L. Telli, MD

The Ohio State University/The James Cancer Hospital and Solove Research Institute

James W. Rocco, MD, PhD

University of California San Francisco/Helen Diller Family Comprehensive Cancer Center

Thomas A. Hope, MD

University of Massachusetts/UMass Cancer Center

Jan Cerny, MD, PhD

University of North Carolina at Chapel Hill/Lineberger Comprehensive Cancer Center

Lisa A. Carey, MD

University of Pennsylvania/Abramson Cancer Center

Jennifer R. Eads, MD

Wisconsin NCORP

Kurt R. Oettel, MD

 

Accrual, Scientific Contribution and Administrative Participation

Institution

Principal Investigator

Emory University/Winship Cancer Institute

Charles A. Staley III, MD

Fox Chase Cancer Center

Lori J. Goldstein, MD

Gulf South Minority Underserved NCORP

Augusto C. Ochoa, MD

Johns Hopkins University/The Sidney Kimmel Comprehensive Cancer Center

Julie R. Brahmer, MD

Mayo Clinic Cancer Center

Thomas M. Habermann, MD

Rutgers Cancer Institute of New Jersey

Howard S. Hochster, MD

The University of Texas/MD Anderson Cancer Center

PI in Transition

University of Wisconsin/UW Carbone Cancer Center

Kari B. Wisinski, MD

Vanderbilt University/Vanderbilt-Ingram Cancer Center

Jordan D. Berlin, MD

Washington University at St. Louis/Siteman Cancer Center

Barry A. Siegel, MD


Accrual and Scientific Contribution

Institution

Principal Investigator

Dana-Farber/Harvard Cancer Center

Frank S. Hodi, Jr., MD

Froedtert & Medical College of Wisconsin

Timothy S. Fenske, MD, MS

Moffitt Cancer Center

Jhanelle E. Gray, MD

Yale University/Yale Cancer Center

Barbara A. Burtness, MD


Accrual and Data Management

Institution

Principal Investigator

Essentia Health NCORP

Bret E. Friday, MD

Georgia NCORP

Guilherme Cantuária, MD, PhD

Upstate Carolina NCORP

James D. Bearden III, MD


Accrual

Institution

Principal Investigator

AHN Cancer Center-Allegheny General Hospital

Nathan Bahary, MD PhD

Carle Cancer Center NCORP

Kendrith M. Rowland, MD

CERIM (Argentina)

Daniel E. Lehrer, MD

Cleveland Clinic Mercy Hospital

Mitchell Haut, MD

Dickstein Cancer Treatment Center at White Plains Hospital Center

Karen B. Green, MD

Memorial Hermann-Texas Medical Center

Syed H. Jafri, MBBS

Stamford Health Bennett Cancer Center

Salvatore A. Del Prete, MD

Tufts Medicine Cancer Center

Rachel J. Buchsbaum, MD

Yonsei University /Yonsei Cancer Hospital (South Korea)

Joohyuk Sohn, MD

 
Scientific Contribution

Institution

Principal Investigator

University of Washington/Fred Hutchinson Cancer Center

Evan Y. Yu, MD


Data Management
 

Institution

Principal Investigator

Aurora NCORP

Thomas J. Saphner, MD

Cancer Research Consortium of West Michigan NCORP

Kathleen J. Yost, MD, BS

Puerto Rico Minority Underserved NCORP

Luis J. Santos Reyes, MD

 

Leave a Reply

Your email address will not be published. Required fields are marked *